Impact of albumin to globulin ratio on survival outcomes of patients with metastatic renal cell carcinoma.

Aktepe, Oktay Halit; Güner, Gürkan; Güven, Deniz Can; Taban, Hakan; Yildirim, Hasan Çagri; Sahin, Taha Koray; Ardiç, Fadime Sinem; Yeter, Haci Hasan; Yüce, Deniz; Erman, Mustafa

Aktepe, Oktay Halit; Güner, Gürkan; Güven, Deniz Can; Taban, Hakan; Yildirim, Hasan Çagri; Sahin, Taha Koray; Ardiç, Fadime Sinem; Yeter, Haci Hasan; Yüce, Deniz; Erman, Mustafa.

Afiliação

Aktepe OH; Hacettepe University Cancer Institute, Ankara, Turkey.
Güner G; Hacettepe University Cancer Institute, Ankara, Turkey.
Güven DC; Hacettepe University Cancer Institute, Ankara, Turkey.
Taban H; Hacettepe University Cancer Institute, Ankara, Turkey.
Yildirim HÇ; Hacettepe University Cancer Institute, Ankara, Turkey.
Sahin TK; Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Ardiç FS; Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Yeter HH; Department of Nephrology, Gazi University Faculty of Medicine, Ankara, Turkey.
Yüce D; Department of Preventive Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Erman M; Department of Preventive Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

Turk J Urol ; 47(2): 113-119, 2021 Mar.

Article em En | MEDLINE | ID: mdl-33819441

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Turk J Urol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google